Literature DB >> 22795619

Psoriasin (S100A7) promotes migration of a squamous carcinoma cell line.

Jason Winston, Ronald Wolf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795619     DOI: 10.1016/j.jdermsci.2012.06.009

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  6 in total

1.  Bioinformatic analysis identifies epidermal development genes that contribute to melanoma progression.

Authors:  Gastón Barbero; María Victoria Castro; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  Med Oncol       Date:  2022-07-14       Impact factor: 3.738

Review 2.  Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis.

Authors:  Eva Hattinger; Stephanie Zwicker; Thomas Ruzicka; Stuart H Yuspa; Ronald Wolf
Journal:  Curr Opin Pharmacol       Date:  2013-05-09       Impact factor: 5.547

Review 3.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

4.  Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.

Authors:  Nadine Herwig; Birgit Belter; Susann Wolf; Cathleen Haase-Kohn; Jens Pietzsch
Journal:  J Cell Mol Med       Date:  2016-03-01       Impact factor: 5.310

5.  The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.

Authors:  Mu Hu; Lin Ye; Fiona Ruge; Xiuyi Zhi; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2012-12-10       Impact factor: 4.430

6.  Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.

Authors:  Jia Liu; Zehang Zhao; Zhiwei Sun; Chang Liu; Xiaojing Cheng; Fiona Ruge; Yong Yang; Wen G Jiang; Lin Ye
Journal:  Oncol Rep       Date:  2019-12-24       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.